ENvue Medical, Inc. (FEED)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 350K 700K 1.1M Q3 '24: 376K Q4 '24: 444K Q1 '25: 1M Q2 '25: 494K Q3 '25: 722K Q4 '25: 312K Q1 '26: 653K Q2 '26: 239K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

-450K -300K -150K 0 150K 300K 450K Q3 '24: 133K Q4 '24: 283K Q1 '25: 369K Q2 '25: -35K Q3 '25: 189K Q4 '25: -370K Q1 '26: -55K Q2 '26: -266K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income Quarterly

-18M -12M -6M 0 6M 12M 18M Q3 '24: -970K Q4 '24: -1.4M Q1 '25: -1.9M Q2 '25: -4M Q3 '25: -2.2M Q4 '25: -14.8M Q1 '26: -3.7M Q2 '26: -5.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-15M -10M -5M 0 5M 10M 15M Q3 '24: -998K Q4 '24: -1.4M Q1 '25: -1.9M Q2 '25: -4M Q3 '25: 510K Q4 '25: -12.9M Q1 '26: -3.8M Q2 '26: -4.9M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 250K 500K 750K Q3 '24: 243K Q4 '24: 161K Q1 '25: 656K Q2 '25: 529K Q3 '25: 533K Q4 '25: 682K Q1 '26: 708K Q2 '26: 505K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '24: -836K Q4 '24: -548K Q1 '25: -1.3M Q2 '25: -3.4M Q3 '25: -2M Q4 '25: -2.7M Q1 '26: -4.3M Q2 '26: -2.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '24: -836K Q4 '24: -548K Q1 '25: -1.3M Q2 '25: -3.4M Q3 '25: -2M Q4 '25: -2.7M Q1 '26: -4.3M Q2 '26: -2.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 2.5M 5M 7.5M Q1 '24: 247K Q2 '24: 25.3K Q3 '24: 280.3K Q1 '25: 62.6K Q2 '25: 484.6K Q3 '25: 858.4K Q1 '26: 3.3M Q2 '26: 6.2M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-210.00 -140.00 -70.00 0.00 70.00 140.00 210.00 Q2 '23: -3.42 Q3 '23: -3.16 Q4 '23: -23.33 Q1 '24: -20.28 Q2 '24: -46.81 Q3 '24: -49.95 Q4 '24: -157.28 Q1 '25: -189.56 Q2 '23 Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.